Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia

Journal of Hematology & Oncology
Jingjing WuDelong Liu

Abstract

Targeted therapy has been the forefront of cancer treatment. Cancer immunotherapy is the most recent focus. In addition, novel immunotherapeutics targeting B cell receptor signaling (e.g., ibrutinib), T cell receptor ( e.g., CART19), and NK cells (e.g., AFM13) are being developed. This review summarized the new development in blinatumomab (MT103/MEDI-538), a first-in-class bispecific T engager (BiTE) antibody against CD19/CD3 in patients with relapsed/refractory precursor B cell acute lymphoid leukemia.

References

Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·M MackP Kufer
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P HolligerG Winter
Oct 31, 2002·Immunologic Research·Robert H CarterStephen Brooks
Mar 22, 2005·Immunologic Research·Christopher J Del NagroRobert C Rickert
Jun 29, 2007·Blood·Jacob M Rowe, Anthony H Goldstone
Feb 5, 2008·Seminars in Immunology·Robert H Carter, Riley Myers
Dec 23, 2008·Seminars in Hematology·Nicola Gökbuget, Dieter Hoelzer
May 21, 2009·Leukemia & Lymphoma·Dirk NagorsenGerhard Zugmaier
Nov 5, 2010·The New England Journal of Medicine·Anas YounesAndres Forero-Torres
Mar 23, 2011·Experimental Cell Research·Dirk Nagorsen, Patrick A Baeuerle
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Oct 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Veronique BlancJohn M Lambert
May 2, 2012·The Journal of Clinical Investigation·Elaine Y ChungAndrei Thomas-Tikhonenko
Sep 4, 2012·Pharmacology & Therapeutics·Dirk NagorsenRalf Bargou
Dec 6, 2012·Experimental Hematology & Oncology·Kemeng WangDelong Liu
Dec 18, 2012·Blood·Stephen J Forman, Jacob M Rowe
Dec 22, 2012·Blood·Renato Bassan
Jan 5, 2013·Journal of Hematology & Oncology·James D MellorAlexander Dobrovic
Mar 28, 2013·Journal of Hematology & Oncology·Manujendra N SahaHong Chang
Apr 4, 2013·Cancer Discovery·Michel SadelainIsabelle Rivière
Apr 17, 2013·Journal of Hematology & Oncology·Akintunde AkinleyeDelong Liu
Apr 27, 2013·Journal of Hematology & Oncology·Tiangui HuangDelong Liu
Apr 30, 2013·Current Opinion in Chemical Biology·Stanley R Frankel, Patrick A Baeuerle
Jun 19, 2013·Journal of Hematology & Oncology·Yanmin ZhaoGuoqing Wei
Jul 9, 2013·Journal of Hematology & Oncology·Ethan Q HanShuang-yin Han
Jul 16, 2013·Journal of the National Cancer Institute·Patrizia LeoneVito Racanelli
Aug 21, 2013·Journal of Hematology & Oncology·Akintunde AkinleyeDelong Liu
Nov 23, 2013·Journal of Hematology & Oncology·Akintunde AkinleyeDelong Liu
Dec 7, 2013·Journal of Hematology & Oncology·Muhammad FurqanDelong Liu
Jan 10, 2014·The New England Journal of Medicine·Valentin GoedeMichael Hallek
Jan 30, 2014·Experimental Hematology & Oncology·Aileen NoveroDelong Liu
Apr 16, 2014·Journal of Hematology & Oncology·Caroline S BretonJonathan Back

❮ Previous
Next ❯

Citations

Jul 5, 2016·International Journal of Molecular Sciences·Laura EsserIngo Schmidt-Wolf
Dec 16, 2016·Expert Opinion on Biological Therapy·Jogender Tushir-Singh
Apr 11, 2018·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Dana A Emerson, William L Redmond
Nov 22, 2018·Preparative Biochemistry & Biotechnology·Fatemeh NaddafiFatemeh Davami
Jan 14, 2018·Journal of Hematology & Oncology·Julian A Marin-AcevedoYanyan Lou
Feb 2, 2018·Biomarker Research·Zhenguang Wang, Weidong Han
Mar 26, 2019·Expert Review of Clinical Pharmacology·Davide BusatoMichele Dal Bo
Apr 25, 2019·Journal of Hematology & Oncology·Hongbing MaYuping Gong
Sep 4, 2016·Journal of Hematology & Oncology·Jingjing WuDelong Liu
Mar 3, 2020·Chemical Communications : Chem Comm·Abhirup MukherjeeRavi S Kane
Apr 30, 2020·Current Opinion in Allergy and Clinical Immunology·Judit Fazekas-SingerErika Jensen-Jarolim
May 21, 2019·Oncotarget·Malalage N PeirisDaniel J Donoghue
Oct 25, 2016·Oncotarget·Jingjing WuDelong Liu
Aug 16, 2019·Journal of Experimental & Clinical Cancer Research : CR·Shengnan YuKongming Wu
Nov 22, 2015·Journal of Hematology & Oncology·Shundong CangDelong Liu
Mar 10, 2016·Journal of Hematology & Oncology·Jingjing WuDelong Liu
Feb 23, 2017·Journal of Hematology & Oncology·Zhenguang WangWeidong Han
Oct 20, 2018·Cellular and Molecular Life Sciences : CMLS·Thomas SchlakeIngo Jordan
Nov 12, 2019·Experimental Hematology & Oncology·Juanjuan ZhaoDelong Liu
Jul 30, 2017·Journal of Hematology & Oncology·Delong Liu, Aleksandra Mamorska-Dyga
Aug 20, 2017·Journal of Hematology & Oncology·Guoqing WeiYanmin Zhao
Jul 14, 2018·Cellular & Molecular Immunology·Xiaolei LiWeidong Han
Apr 25, 2017·Journal of Hematology & Oncology·Annie Im, Steven Z Pavletic
Jun 1, 2018·Journal of Immunology Research·Shangjun SunYang Fu
Sep 8, 2018·Frontiers in Oncology·Henry T Marshall, Mustafa B A Djamgoz
Sep 29, 2020·Drug Design, Development and Therapy·Lei HuangJianmin Fang
Feb 18, 2016·Journal of Hematology & Oncology·Zhenbo TuQiuping Zhang
Sep 22, 2017·Journal of Hematology & Oncology·Shengnan YuKongming Wu
Jul 12, 2019·Frontiers in Immunology·Mingpeng FuPing Lei
Feb 22, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Olivia CampagneDonald E Mager
Nov 17, 2020·International Journal of Biological Macromolecules·Seyed Samad HosseiniMichael R Hamblin

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00274742
NCT01209286
NCT01466179
NCT02143414
NCT02003222

Software Mentioned

BiTE

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.